Okyo PharmaOKYO
13F holders, Q4 2024 (December 31)7holders +1
1new positions
0sold out
2famous investors
$1.15avg. 13F price*
At the end of Q4 2024, 7 institutions reported holding Okyo Pharma Ltd. (OKYO) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Barclays PLC ($1.1M), Citadel Advisors ($24K) and Renaissance Technologies ($19K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Okyo Pharma Ltd.
- CUSIP
- G6724L116
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $19K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 24,826 shares bought, net +24,826 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Barclays PLC | 0.00% | No change | 961,000 | $1.1M |
| Citadel Advisors | 0.00% | Add +39.4% | 20,729 | $24K |
| Renaissance Technologies | 0.00% | New | 16,500 | $19K |
| Cerity Partners LLC | 0.00% | No change | 12,812 | $15K |
| Geode Capital Management, LLC | 0.00% | No change | 12,090 | $14K |
| UBS Group AG | 0.00% | Add +471.1% | 2,998 | $3K |
| Continuum Advisory, LLC | 0.00% | No change | 50 | $58 |
"% of holder's portfolio" is OKYO's weight in each manager's 13F, not the share of Okyo Pharma Ltd. the manager owns.